023-04-03 00:59:33 ET

Timber Pharmaceuticals press release ( NYSE: TMBR ): FY GAAP EPS of -$9.19.
Revenue of $0.08M (-91.0% Y/Y) misses by $0.72M .
At December 31, 2022, Timber had approximately $9.1M in cash, which included $1.3M in gross proceeds raised through the sale of common stock and warrants in October 2022.
For further details see:

Timber Pharmaceuticals GAAP EPS of -$9.19, revenue of $0.08M misses by $0.72M
News Provided by SeekingAlpha via QuoteMedia

Attachments

Disclaimer

Timber Pharmaceuticals Inc. published this content on 03 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 April 2023 07:38:09 UTC.